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Summary
This chapter describes the presentation and treatment of attention deficit 
hyperactive disorder (ADHD) in adults with intellectual disabilities (ID). ADHD 
is a common condition in children with ID but often goes unrecognised in 
adults. The presentation of ADHD in adults with ID is often complicated by the 
presence of other conditions such as autism. In addition, ADHD impacts on a 
person’s achievements and on their social functioning, so hindering their personal 
relationships. To date there has been no diagnostic tool available to diagnose 
ADHD in adults with ID, although an assessment tool specifically developed 
for the purpose is in development. The approach to the treatment of ADHD in 
adults with ID is same as in the general population, using a combination of 
both pharmacological and non-pharmacological interventions. This is why it is 
important to raise the awareness and understanding of ADHD in adults with ID 
as good treatments are available.
Introduction
ADHD is a common childhood disorder that can persist into adulthood. It 
affects 3% to 4% of children and 1% of adults. It is a neurodevelopmental 
disorder as is ID and autism spectrum disorder (ASD), all of which are lifelong 
conditions affecting several domains of functioning. The age of onset for ADHD 
within DSM-V (American Psychiatric Association, 2013) is before the age of 
12 years. In adults, ADHD commonly occurs with other conditions including 
ID, anxiety, depression, drug and alcohol use and antisocial behaviour. For 
children with ADHD, common co-morbid conditions include oppositional 
defiant and conduct disorders, anxiety and mood disorders, tics or Tourette’s 
syndrome and autism.
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A third of children with ADHD go on to have the diagnosis as adults, whereas 
two thirds show a persistence of symptoms that impacts on their functioning as 
adults. ADHD can impact on the social, academic and occupational functioning 
of a person, therefore not just on what they may achieve at school but on their 
personal relationships as children and adults.
ADHD is three times more common in individuals with ID than in the general 
population with some studies indicating that up to a third of children with ID are 
affected by symptoms of ADHD. For those with ASD, up to 50% may be affected 
with symptoms of ADHD. The prevalence of ADHD is equal in boys and girls for 
those with ID, which compares to the findings in the general population in which 
five boys are identified to every one girl. This gender difference may in part be 
due to less awareness of ADHD occurring in girls.
Studies indicate there is a significant genetic component that influences the risk 
for developing ADHD. The risk for first degree relatives is four to 10 times the 
population rate and the prevalence of ADHD among first degree relatives is in 
the range 20 to 50%. In addition, there are environmental factors associated with 
ADHD. These include exposure of the foetus to alcohol, nicotine, drugs, high blood 
pressure, maternal stress during pregnancy, being born preterm and low birth 
weight. However, these environmental factors (which are associations and not 
shown to be direct causes) may be modified by genetic factors.
ADHD and ID
ADHD is common in people with ID, with those less able at more risk of showing 
symptoms. Traditionally, there has not been a focus on ADHD in adults with ID 
despite it being one of the most common disorders in childhood. 
There is increasing evidence to support the diagnosis of ADHD in adults with 
ID and that this group of the population is at increased risk for the condition 
(Xenitidis et al, 2014). Until recently, the research focused on children with 
mild ID, confirming an increase of ADHD symptoms in this group (Simonoff et 
al, 2007). The challenge has been to establish how best to apply the diagnostic 
criteria in people with ID, and others have questioned if ADHD can be diagnosed 
in children with low IQ. A further complication is that the inattention and 
associated deficits of executive function in ADHD may result in lower IQ scores, 
but this will not necessarily indicate ID as defined by the international diagnostic 
systems (Ek et al, 2011). In adults with ADHD, the severity of symptoms has a 
negative collation with IQ scores. One study examining symptoms of ADHD in 
adults with ID found that there was greater severity of (adult and childhood) 
symptoms compared to people with ADHD with no ID. It was also the case that 
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the latter group could expect a greater improvement of symptoms in adulthood 
than those with ID (Xenitidis et al, 2014). 
Currently there are no specific rating scales designed to assess ADHD in adults 
with ID that work with the ICD-10 and DSM-V diagnostic systems. La Malfa 
et al (2008) reported on the use of the Conner’s Adult ADHD rating scale in 46 
adults with ID, finding an ‘ADHD-positive’ prevalence of 19.6%. There is also an 
increasing recognition of the need to screen for the neurodevelopmental disorders 
as defined by DSM-V to identify when ADHD and ID occur together, especially in 
at-risk populations such as those in the criminal justice system (McCarthy et al, 
2015). The key area for future research, therefore, is to develop a validated tool 
to diagnose ADHD in adults with ID that will lead to the development of studies 
looking at response to treatment, and so increase understanding of the long-term 
outcomes in adults with ID and comorbid ADHD. 
Diagnosing ADHD
Central to the diagnostic criteria for ADHD in children in DSM-V is a persistent 
pattern of inattention and/or hyperactivity-impulsivity that interferes with 
functioning or development as characterised by:
1. Inattention: six or more symptoms (which have been present for at least six 
months) that are inconsistent with developmental level and that negatively 
impact directly on social and academic/occupational activities. The individual may: 
overlook details; have difficulties remaining focused on conversations; seem like 
their mind is elsewhere; fail to finish tasks; fail to meet deadlines; have problems 
completing forms; lose items such as keys or phones; be easily distracted and often 
forgetful in daily activities such as keeping appointment and paying bills.
2. Hyperactivity and impulsivity – at least six symptoms: often fidgets; restless; 
often ‘on the go’; talking excessively; unable to wait turns in a conversation; 
intrusion into or taking over what others are doing.
For older adolescents and adults (age 17 and above) at least five symptoms are 
required.
DSM-V notes that although motor symptoms of hyperactivity become less obvious 
in adolescence and adulthood, difficulties persist with restlessness, inattention, 
poor planning and impulsivity. DSM-V also stipulates that symptoms are 
excessive and maladaptive for developmental level, which is a very important 
issue to consider when making a diagnosis in a person with mild ID compared to 
a person with severe ID. 
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The current severity of ADHD is also specified in DSM-V as below:
■■ Mild – few if any symptoms in excess of those required to make the diagnosis 
are present, and symptoms result in no more than minor impairments in social 
or occupational functioning.
■■ Moderate – symptoms or functional impairment between ‘mild’ and ‘severe’ are 
present.
■■ Severe – many symptoms in excess of those required to make the diagnosis, or 
several symptoms that are particularly severe are present, or the symptoms 
result in marked impairment in social or occupational functioning.
DSM-V states that ADHD can be diagnosed with known genetic syndromes such 
as fragile X syndrome, velo-cardiofacial syndrome and Down’s syndrome. 
Assessment of ADHD
There are a number of screening tools available, but it is important to remember 
that symptoms of ADHD start in childhood, are chronic, and do not fluctuate 
overtime. The hyperactive and impulsive symptoms do modify more than the 
attentional symptoms.
Diagnosis is based on a careful assessment, including developmental history 
and a detailed psychiatric history. The use of informants is helpful specifically 
in recognising the level of impairment on functioning. There are screening 
instruments available for identifying adults with ADHD such as the six item World 
Health Adult Self Report Scale (ASRS). For diagnosis, there are number tools such 
as the Conners’ Adult ADHD Rating scale and Diagnostic Interview for ADHD in 
adults (DIVA), which is available free on line at www.divacenter.eu. The DIVA has 
now been developed into a version for use with adults with ID known as DIVA-ID 
and will soon be available for wider use.
Other symptoms that are commonly associated with ADHD but not necessarily 
a requirement of the diagnostic systems include procrastination, low tolerance of 
frustration so seeming on a ‘short fuse’, and mood lability. Mood lability is very 
common, with mood changes occurring a number times a day, and low self-esteem 
is also very common due to earlier experiences of failure and rejection. Adults with 
ADHD do not settle with age and are often underachievers but will change and/or 
lose jobs and relationships through being fired or being bored. The clinical picture 
of ADHD is commonly complicated by frequent comorbid conditions that may occur, 
making a complex picture of conditions to unravel and treat (Hellings et al, 2016).
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Parents and carers may report the person with ID to be moody, aggressive or 
anxious so there may be a response to prescribe medication such as antipsychotics 
or mood stabilisers. However, this would result in the person not receiving 
the most appropriate treatment for their ADHD, and therefore missing the 
opportunity to have much better control of their ADHD symptoms.
Types of ADHD
How ADHD presents will differ by individual. There are three main ways it can 
present: 
1. ADHD where the person is predominantly hyperactive and or impulsive. The 
person with this will feel the need to move constantly. They may also struggle 
with making good choices as they become impatient as their impulse control 
can be affected. Although there may be some issues with inattention, this is 
not seen as a problem.
2. ADHD where the person is predominantly inattentive and has difficulty paying 
attention. The person is easily distracted but not usually impulsive or hyperactive. 
This can often be missed as the person is not seen as disruptive and can even be 
seen as shy, whereas those in the first group are often seen as disruptive.
3. ADHD, combined presentation. This is the most common type of ADHD, where 
the person experiences symptoms in both types 1 and 2. 
ADHD and other mental disorders
Diagnosing ADHD in people with ID can be challenging as it can be mistaken for 
a behavioural issue or a mental illness where there is an increase in activity such 
as hypomania, or where there is a lack of attention paid due to poor concentration, 
such as depression. However, it is equally important to ensure that symptoms are 
not better explained by an underlying mental health problem. Some of the ways 
to distinguish between ADHD and other mental health problems is to look at the 
presentation in context e.g. chronicity of symptoms, recent stressful life events, 
severity of symptoms or other medical conditions such as infection.
In addition, ADHD shares some of the symptoms of borderline personality 
disorder such as impulsivity, mood instability and feelings of boredom. 
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Treatment
Symptoms of ADHD can be treated effectively in both children and adults. The 
effects of both stimulant medication and atomoxetine on the core symptoms of 
ADHD are well established. 
Treatment can be broken into pharmacological and non-pharmacological 
interventions. The focus of treatment should focus on improving symptoms and 
functioning. Traditionally, those with ID have been excluded from studies of ADHD 
in the general population as it was felt the symptoms were part of the ID – diagnostic 
overshadowing. Current clinical practice in treating adults with ID presenting with 
ADHD is therefore to apply the current evidence available for the non-ID population 
as described in NICE guidelines for adults with ADHD (NICE, 2008).
Table 9.1 summarises the key treatments for ADHD. The evidence indicates that 
children with ID and ADHD may not have the same response to psychostimulant 
medication, such as methylphenidate, as other children.
Table 9.1: Treatments for ADHD
Pharmacological Non-pharmacological
There are five types of medication 
licensed for the treatment of ADHD:
■■ Methylphenidate. 
■■ Dexamfetamine.
■■ Lisdexamfetamine.
■■ Atomoxetine.
■■ Guanfacine.
■■ CBT.
■■ Lifestyle and diet.
■■ Behavioural interventions.
■■ Psychoeducation.
■■ Social skills.
■■ Parent education programmes.
(For more information, see NHS Choices: http://www.nhs.uk/Conditions/Attention-
deficit-hyperactivity-disorder/Pages/Treatment.aspx  (accessed December 2017)
Pharmacological
Medicines are not intended to be a cure for ADHD but are designed to help with 
symptoms, for example to make the person more able to concentrate, be less impulsive, 
feel calmer, and take part in things they would not have been able to before, such 
as learning. In the UK, all of these medications are licensed for use in children and 
teenagers and are commonly prescribed as extended release preparations, which have 
a duration of action of many hours, possibly allowing a one-a-day dose. Atomoxetine is 
also licensed for use in adults who had symptoms of ADHD.
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It is reported that children with ADHD may be more at risk of the side effects 
from the stimulants as described below. Stimulants may worsen self-injury 
behaviour so use of non-stimulant ADHD medication may be more suitable.
What side effects can stimulants cause?
Side effects often happen early in treatment and for most people are mild and 
short-term. Common side effects can include:
■■ Decreased appetite/weight loss.
■■ Sleep problems.
■■ Social withdrawal.
■■ Rebound effect (increased activity or a bad mood as the medication wears off).
■■ Tics.
■■ Stomach aches.
■■ Mood swings.
■■ Dizziness.
■■ Increase in blood pressure or heart rate.
■■ Bizarre behaviour.
■■ Growth delay in children.
There are a number of ways side effects can be helped including: 
■■ Changing the dose or time of medicines.
■■ Trying a different type of medication, for example trying a different stimulant 
or trying a non-stimulant medicine.
Non-pharmacological
In terms of non-pharmacological treatment, education (psychoeducation) of 
individuals, carers and parents is often used. In terms of adult treatments, 
psychological intervention such as cognitive behaviour therapy (CBT) is often 
used, which helps the person to change the way they think and behave by looking 
at how they interpret the relationship between their thoughts and behaviours. 
Some interventions are used both for adults and children such as social skills 
training, which can incorporate roleplay situations, to show how the person’s 
behaviour affects others.
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Another issue often overlooked is diet, as some types of food may worsen ADHD 
symptoms, for example sugar, food additives and caffeine. There are also some food 
supplements that may reduce symptoms such as omega-3 and omega-6 fatty acids, 
although there is currently little evidence as to whether this is effective or not. 
Case study: Paul
This is a case example of a failure to recognise ADHD in both childhood and 
in adult life leading to the diagnosis of a personality disorder in adult life and 
misuse of alcohol with a devastating impact on the well-being of Paul.
Paul is a 30-year-old man with mild learning disabilities and a diagnosis of 
emotionally unstable personality disorder. He has had a history of behavioural 
problems since childhood, including disruptive behaviour, fidgeting, struggling 
at school and having severe temper tantrums. As a result he has presented as 
impulsive, disorganised and chaotic throughout his adult life, which has led to 
multiple presentations to hospital with overdoses and self-harming behaviour, 
along with a long history of alcohol misuse and accompanying mood instability. 
Failure to recognise Paul’s presentation because of a lack of awareness of ADHD 
has led to a diagnosis of personality disorder.
Case study: Mark
This case example is an example of making an early diagnosis and providing 
appropriate treatment.
Mark is 14-year-old boy with moderate to severe ID. He presented with many 
behavioural difficulties along with restlessness and hyperactivity, which was 
initially put down to his ID. These behaviours and his presentation caused 
major difficulties at his special school in terms of engaging and supporting him. 
On further assessment it was recognised that his hyperactivity and restlessness 
were much more than expected for his developmental level. Following 
psychiatric assessment, Mark was diagnosed with ADHD, started on a stimulant 
and provided with social skills training. Following the initial phase of treatment 
there was significant improvement in his behaviour and he is no longer being 
oppositional, is able to participate in family events and to go out to play with 
his friends.
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Case study: David 
This is a case example of a person being recognised as having ADHD in childhood 
but where there was no follow up into adult services to ensure he continued with 
appropriate treatment. This lack of appropriate treatment is probably contributing 
to his current presentation.
David is 22-year-old man with mild ID, diagnosed with personality disorder and 
recognised as having had ADHD in childhood. He has recently been in prison for 
threats to his ex-partner. In prison, David self-harmed and, due to his continuing 
vulnerability on release and an increase in his threatening behaviour, he is admitted 
to an intensive care mental health ward under Section 3 of the Mental Health Act. On 
the ward he is assaulting staff, damaging property and self-harming by cutting himself 
with broken objects. He is diagnosed with adult ADHD and commenced on stimulant 
treatment. On leaving children’s services at the age of 18 years, David’s ADHD had not 
been seen as a problem and had not previously been picked up as an adult.
Key learning points
■■ ADHD is a common condition in people with ID and can persist throughout 
adult life.
■■ ADHD can be misdiagnosed as personality disorder or mood disorder as they 
share some traits.
■■ There is a need to improve recognition and diagnosis of ADHD in people with 
ID to improve outcomes in both childhood and adult life.
■■ ADHD can have a significant impact on the functioning of a person with ID, 
including on their personal relationships.
■■ There is a good response to treatment so it is important to recognise and 
diagnose ADHD in a person with ID.
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